We are Advancing Immunology Solutions for a Better Future|Thomas K Equels, Chief Executive Officer,Hemispherx BioPharma 00:10:00
THOMAS K. EQUELS, M.S., J.D. has been the Chief Executive Officer of AIM ImmunoTech Inc. since February 2016. Additionally, he has served as a Director on the company’s Board of Directors since 2008. Mr. Equels previously served as the company’s Secretary from 2008 to 2016, its General Counsel from 2010 to 2016, and its Chief Financial Officer from December 2013 to February 2016. Mr. Equels was formerly the President and Managing Director of the Equels Law Firm in Miami, Fla. For over a quarter century,
